Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.

Urology - 1 Jul 2004

Ito Masaaki, Habuchi Tomonori, Watanabe Jun, Higashi Shin, Nishiyama Hiroyuki, Wang Lizhong, Tsuchiya Norihiko, Kamoto Toshiyuki, Ogawa Osamu

Abstract excerpt

OBJECTIVES: To evaluate the prognostic value of CCND1 polymorphism in superficial and invasive transitional cell cancer of the bladder. METHODS: CCND1 polymorphism of blood DNA from patients with transitional cell cancer of the bladder was evaluated using the polymerase chain reaction-restriction fragment length polymorphism method. RESULTS: No statistically significant difference was found in the recurrence-free...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Alkylating
Share to BCG Vaccine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma in Situ

Share to Carcinoma, Transitional Cell

Share to Life Tables

Share to Mitomycin

Share to Proto-Oncogenes

Share to Salvage Therapy

Source

Identifiers

PMID: 15245939
DOI: 10.1016/j.urology.2004.03.001

Genes

CCND1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.PMID 15245939Read ↗

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.Semantic proximity Read ↗

Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer.Semantic proximity Read ↗

Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.Semantic proximity Read ↗

The CCND1 G870A polymorphism and susceptibility to bladder cancer.Semantic proximity Read ↗

Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.Semantic proximity Read ↗

Insertion/deletion polymorphism in the promoter of NFKB1 as a potential molecular marker for the risk of recurrence in superficial bladder cancer.Semantic proximity Read ↗

DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.Semantic proximity Read ↗

A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.Semantic proximity Read ↗

Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.Semantic proximity Read ↗

Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?Semantic proximity Read ↗

Insertion/deletion polymorphism in the promoter region of NFKB1 gene increases susceptibility for superficial bladder cancer in Chinese.Semantic proximity Read ↗

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.